Logo Cellply

Webinar: Rapid single cell functional characterization for cell therapy potency

Webinar

Webinar: Rapid single cell functional characterization for cell therapy potency

EXPERT INSIGHT WEBINAR

See how VivaCyte immune cell potency measurement is guiding selection and predictive screening

In this webinar DKFZ Heidelberg’s DNA vector expert Dr Richard Harbottle and Cellply’s co-founder Dr Massimo Bocchi will introduce the VivaCyte characterization platform and discuss how Dr Harbottle’s team is using VivaCyte to accelerate their work on the measurement and optimization of potency and fitness of novel TCR-T cell therapies.

Duration: 30 mins

Discover:

  • VivaCyte and explore how this next generation single-cell functional analysis platform provides actionable insights that are streamlining cell therapy discovery and development.
  • The novel microfluidics and ability to repeatedly exchange media around the cells during an assay that allows VivaCyte to provide true flexibility of in-depth single-cell level characterization of your immune cell candidate.
  • Understand how you can investigate and rapidly characterize every cell for both function and phenotype to assess potency, fitness, and the impact of production processes.

PRESENTERS

As a novel therapeutic modality, cell-based therapy is revolutionizing the pharmaceutical industry. As this nascent field of more effective, often curative, living cells rapidly evolves its goal is clear – to deliver therapies that induce a targeted and persistent killing effect.

Increasing understanding of the complexity that underlies these heterogenous therapies, and the impact on potency and persistence, is critical as the industry strives to better define and control these vital therapies, while decreasing their overall cost.

Dr. Richard Harbottle - Head of DNA Vector Lab at DKFZ

Application of this modality is rapidly broadening beyond the initial hematological cancer focus and moving to address solid tumors and inflammatory diseases. The pressure is on to deliver analytical characterization tools that increase the depth, breadth, and robustness of measurement currently available across R&D and into manufacturing.

Dr. Massimo Bocchi - Co-founder of Cellply
To find out more, please contact using the form below.
continue reading

You may also like

Webinar

Webinar: A new automated potency analysis technique for suspension cells

25 November 2024
Events

Cellply Named in Cohort 2 of EIC Scaling Club for EU Deep Tech Scale-ups

6 November 2024
Events

Cellply Introduces Revolutionary High-Throughput Potency Analysis Technique at SITC 39th Annual Meeting

31 October 2024
Webinar

Webinar: Uncovering hidden immune cell killing to understand anti-tumor activity

2 October 2024
Webinar

Cellply is pleased to announce its participation in European Biotech Week 2024 hosting an open webinar exploring the unique assay flexibility of VivaCyte

9 September 2024
News

Eurofins Biopharma Product Testing (BPT) Italy and Cellply announce strategic partnership to foster cell and gene therapy development through single-cell characterisation

29 August 2024
News

Cellply passed the phase 2 of Call4Innovit program and will go to San Francisco

23 May 2024
Events

Advancing TCR-based Cell Therapies & Bispecific Approaches

24 April 2024
Press release

Nature Biotechnology publishes research from DKFZ and Cellply highlighting novel approach for accelerating cellular immunotherapy development

19 March 2024
Events

Dual attendance for Cellply at March’s leading events in the cell therapy industry.

18 March 2024
Events

Launch of VivaCyte® at Advanced Therapies Week 2024

26 January 2024
News

Cellply launches its end-to-end single cell potency characterization platform VivaCyte

17 January 2024
Events

Cellply at Advanced Therapies Week 2024

4 January 2024
News

Cellply – Fesr programme 2021-2027

28 December 2023
Press release

Cellply concludes a new internal round of €3.6 million and extends the round to new investors!

27 September 2023
News

CellPly announces acceptance of one abstract at the CICON23 conference

18 September 2023
Press release

CellPly announces Emiliano Spagnolo as the new CEO

27 July 2023
News

L’innovazione Cellply in un articolo sulla rivista Le Scienze

4 March 2020
Events

Cellply to present new method for evaluating immunotherapy efficacy at the 61th ASH Annual Meeting

25 November 2019
News

Cellply wins the €300k Gaetano Marzotto prize and Unicredit StartLab prize

22 November 2018
Events

Cellply invited to present at the World Health Summit 2019

22 October 2018
News

Cellply selected as finalist at Lyfebulb Oncology Award

1 March 2018
Events

Cellply abstract accepted at the AACR 2018 Annual Meeting

4 February 2018
Press release

Cellply and Sant’Orsola-Malpighi Polyclinic to present one abstract on AML patient stratification with the Open Microwell platform at the 58th ASH Annual Meeting

4 November 2016
News

Cellply wins an H2020 SME Instrument Phase 1 grant

20 October 2016
Keep in touch

Need some infos?

Drop us a line or give us a ring. We love to hear from you and are happy to answer any questions.